Phone: +43 699 18904206
Geert C. Mudde received a Ph.D. in immunology from the University of Utrecht in 1985 and started his international professional career at the Swiss Institute for Asthma and Allergy Research in Davos in 1989. In 1992 he joined the pharmaceutical/biotech industry, where he held several senior management positions at the Novartis Research Institute in Vienna, Austria, at the Parke Davis Research Institute in Fresnes, France, at Ingenium Pharmaceuticals, Martinsried, Germany and at igeneon in Austria. In 2006, while joining Baxter BioScience in Vienna, he also co-founded the biotech company f-star, where he served as CSO until the foundation of the allergy-focused biotech start-up S-TARget therapeutics in 2010. Together with Christof Langer he co-founded OncoQR ML in 2013.